Nordion Inc (NDN.TO)

HOLD
Steady. Highly skilled operation.
BUY
Very favourable to this stock. Have a sector out-perform on it. One of the top 3 Canadian names. Disappointing last quarter is not likely to be repeated. Buy on this weakness.
BUY
Has significant overhead resistance at $25 and strong support at $18. Expects it to move up to the $25 area.
DON'T BUY
Hasn't done anything for few years, and possibly won't. Fair market value is a little higher than its current price.
PAST TOP PICK
(A top pick Oct 4/03. Up 10%.) Still likes.
BUY
Has been disappointed with execution over the last few years. Feels they are aggressively redressing some of those concerns. Feels the stock is undervalued.
HOLD
Reduced exposure. May do something great in the future. Own very little
DON'T BUY
A good company but they have trouble showing real growth and profitability. Their proteomics seems to be faltering. There is pressure and they may have to restructure.
DON'T BUY
This stock has stalled and is frustrating. Can't see them getting 15% growth as they predicted.
HOLD
Had been a great fan of the Company until last year. Started to lose interest when the CFO left. Expensive.
DON'T BUY
A little bit of dead money right now. All their areas seem to be having troubles. Doesn't see big earnings growth.
WEAK BUY
Relatively solid company. Good cash flow from parts of their business.
DON'T BUY
A frustrating stock. A good company. Needs some kind of catalyst.
DON'T BUY
Building a base and has not broken out above the trend line yet. If you own it, put a stop loss on it around $17.
DON'T BUY
Not much downside risk, but doesn’t expect it to move much. New management is trying to streamline things. No real spark plugs in the company. Dead money.
Showing 31 to 45 of 229 entries